Navigation Links
Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinson's Disease Research Models
Date:10/1/2009

d to facilitate the development of new models that scientists believe will provide a better understanding of Parkinson's disease at the molecular, biochemical, physiological and behavioral levels. This knowledge may, in turn, result in new therapeutic targets and approaches for the treatment of Parkinson's disease.

"Our Foundation's mission is to accelerate the conversion of basic discoveries about Parkinson's disease into practical treatments that will make a difference in patients' lives," said Katie Hood, CEO of The Michael J. Fox Foundation. "To accomplish this, there is a critical need for new research models to more effectively screen potential new therapies, particularly neuroprotective therapies. We're excited about the knockout rat technology developed by Sigma-Aldrich, and hopeful for its prospects to quickly make a major impact on Parkinson's disease drug development efforts and help deliver breakthrough treatments to patients faster."

"The work undertaken and funding provided by The Michael J. Fox Foundation is fundamental to the scientific community's ability to get one step closer to the next generation of Parkinson's disease treatments," added Dr. Edward Weinstein, Director of SAGE Labs at Sigma-Aldrich. "With the power of our CompoZr technology, we are able provide a unique and innovative contribution to furthering research into this debilitating disorder. The models that we are developing may one day help in the development of new therapeutic approaches to a number of diseases. We are excited to have an opportunity to advance scientific understanding in areas that can directly improve the lives of those that suffer with this disease."

Because rats are physiologically similar to humans, they are ideal subjects for modeling human diseases and have been an important species for research in a number of fields including physiology, endocrinology, neurology, toxicology and cancer. Until recently it has been impossible to c
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
4. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
5. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
6. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
7. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
8. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
9. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
10. Families of Spinal Muscular Atrophy Receives FDA Orphan Drug Designation For Quinazoline495 For The Treatment of Spinal Muscular Atrophy
11. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)... Brandeis Medical Center, led by Dr. Emmanuel Brandeis , offers ... tattoo removal experience with the advanced Astanza Duality laser and a ... cosmetic services with cutting edge medical technology and offering expert medical ... has seen a dramatic increase in the presence of tattoo ...
(Date:1/14/2014)... 14, 2014   NuAire , a manufacturer of ergonomically designed ... Hitachi Koki of Japan to sell ... America . NuAire will utilize its network of sales professionals ... Canada to offer assistance in application use, product benefits ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 2011 Hill-Rom Holdings, Inc. (NYSE: HRC ) ... January 26, 2011.  The company will host a webcast the ... EST. Earnings Release:   Hill-Rom,s Fiscal 2011 ... 2010, will be issued to the public after the close ...
... Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), ... today announced that it has completed its previously announced underwritten ... to the public of $7.60 per ADS. Due ... the company sold a total of 13,800,000 ADSs in the ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 First Quarter Earnings Webcast 2Amarin Announces Successful Completion of Offering of American Depositary Shares 2Amarin Announces Successful Completion of Offering of American Depositary Shares 3
(Date:7/9/2014)... the most common type of lung cancer, researchers have ... role in forming tumors. The new knowledge may expand ... genetic changes already are available or are in clinical ... investigators from The Cancer Genome Atlas (TCGA), including researchers ... Harvard Medical School and other institutions, studied tumors from ...
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... July 9, 2014 There has been a ... UT Southwestern Medical Center using MyChart, the online, interactive ... results, communicate with their healthcare providers, schedule appointments, and ... of patients actively using MyChart each year ... year increased more than 10-fold, according to a study ...
(Date:7/9/2014)... reputation for being highly toxic, but when used in the ... to offer potential health benefits in a range of issues, ... compound (AP39), designed and made at the University of Exeter, ... of very small amounts of the substance to the right ... have already found that the compound protects mitochondria the ...
(Date:7/9/2014)... printing on prescription labels handed out by pharmacists ... in taking medication, according to new research by ... Institute for the Blind)., The study, published recently ... that labels on prescription medications dispensed by pharmacies ... legibility. , By simply following recommended guidelines for ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... a way to predict whether women with ductal carcinoma in ... cancer are at risk of developing more invasive tumors ... women with DCIS will have the opportunity to be more ... will have much more information, so they can better know ...
... for Radiation Oncology (ASTRO) has released its Emerging ... body radiotherapy (SBRT) in lung cancer treatment. SBRT ... focused radiation beams to target a well-defined tumor ... planning and precise treatment setup to deliver the ...
... release is available in French . , Ottawa, ... ideas amongst researchers is a fundamental element in turning knowledge ... Thanks to the newly launched PubMed Central Canada (PMC Canada), ... archive of published Canadian health research. PMC Canada ...
... researchers find , WEDNESDAY, April 28 (HealthDay News) -- ... lung disease caused by cystic fibrosis: Which comes first, ... beginning to answer that question, and it looks like ... an assistant professor of internal medicine at the University ...
... ... Air” in HuffPost Living , ... (PRWEB) April 28, 2010 -- Huffington Post blogger and radio host Kathleen ... radio program, The Kathleen Show ., , ,Each week in The Huffington Post ...
... ... , ... 2010 -- AstraZeneca has agreed to pay $520 million in civil fines, penalties and ... care programs in connection with its marketing and promotional practices for the blockbuster atypical ...
Cached Medicine News:Health News:Breakthrough method predicts risk of invasive breast cancer 2Health News:Breakthrough method predicts risk of invasive breast cancer 3Health News:Canada joins international network providing free access to health research 2Health News:Pigs Yield Clues to Cystic Fibrosis-Related Lung Disease 2Health News:The Kathleen Show Launches Weekly Audio Blog on The Huffington Post 2Health News:AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims 2Health News:AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims 3
Microscissors : Horizontal Scissors...
Disposable Microscissors: Vertical, 90...
Microscissors: Eckardt Vertical Retinomy Scissors...
... the original and very popular ... for cutting in the vertical ... curved tips allow greater versatility ... retlna. Tip is shaped like ...
Medicine Products: